Request for Nominations of Candidates To Serve on the Advisory Committee to the Director, Centers for Disease Control and Prevention, 44036 [2014-17736]
Download as PDF
<![CDATA[
44036
Federal Register / Vol. 79, No. 145 / Tuesday, July 29, 2014 / Notices
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated
Federal Officer, OID, CDC, 1600 Clifton
Road NE., Mailstop D10, Atlanta,
Georgia 30333, Telephone: (404) 639–
4461.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–17739 Filed 7–28–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
rmajette on DSK2TPTVN1PROD with NOTICES
Request for Nominations of
Candidates To Serve on the Advisory
Committee to the Director, Centers for
Disease Control and Prevention
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the Advisory Committee to the
Director, Centers for Disease Control
and Prevention (ACD, CDC). This
committee consists of 15 experts in
fields related to health policy, public
health, global health, preparedness,
preventive medicine, the faith-based
and community-based sector, and allied
fields who are selected by the Secretary
of the U.S. Department of Health and
Human Services (HHS). The committee
advises the HHS Secretary and the CDC
Director concerning policy and broad
strategies that will enable CDC to fulfill
its mission of protecting health through
health promotion, prevention, and
preparedness. The committee
recommends ways to prioritize CDC’s
activities, improve results, and address
health disparities. It also provides
guidance to help CDC work more
effectively with its various private and
public sector constituents to make
health protection a practical reality.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishment of the committee’s
mission. Nominees will be selected by
the HHS Secretary or designee from
VerDate Mar<15>2010
15:02 Jul 28, 2014
Jkt 232001
authorities knowledgeable in the fields
of public health as well as from the
general public. Members may be invited
to serve for terms of up to four years.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership shall be
balanced in terms of professional
training and background, points of view
represented, and the committee’s
function. In addition to a broad range of
expertise, consideration is given to a
broad representation of geographic areas
within the U.S., with diverse
representation of both genders, ethnic
and racial minorities, lesbian, gay,
bisexual, and transgender and persons
with disabilities. Nominees must be
U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the
following items:
• Current curriculum vitae, including
complete contact information (name,
affiliation, mailing address, telephone
number, email address);
• A letter of recommendation stating
the qualifications of the candidate.
Nomination materials must be
postmarked by August 31, 2014, and
sent to: Gayle Hickman, Office of the
Chief of Staff, Centers for Disease
Control and Prevention, 1600 Clifton
Road, NE., Mailstop D14, Atlanta,
Georgia 30333, telephone (404) 639–
7158.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–17736 Filed 7–28–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Notice of Hearing: Reconsideration of
Disapproval; Louisiana Medicaid State
Plan Amendments (SPAs) 13–23, 13–25
and 13–28
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of Hearing:
Reconsideration of Disapproval.
AGENCY:
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
This notice announces an
administrative hearing to be held on
September 9, 2014, at the Department of
Health and Human Services, Centers for
Medicare & Medicaid Services, Division
of Medicaid & Children’s Health, Dallas
Regional Office, 1301 Young Street,
Room #801, 8th Floor Dallas, Texas
75202 to reconsider CMS’ decision to
disapprove Louisiana’s Medicaid SPAs
13–23, 13–25 and 13–28.
Closing Date: Requests to participate
in the hearing as a party must be
received by the presiding officer by
August 13, 2014.
FOR FURTHER INFORMATION CONTACT:
Benjamin R. Cohen, Presiding Officer,
CMS, 2520 Lord Baltimore Drive, Suite
L, Baltimore, Maryland 21244,
Telephone: (410) 786–3169.
SUPPLEMENTARY INFORMATION: This
notice announces an administrative
hearing to reconsider CMS’ decision to
disapprove the Louisiana Medicaid
SPAs 13–23, 13–25 and 13–28. CMS
received Louisiana SPAs 13–23 and 13–
25 on June 27, 2013, and 13–28 on July
12, 2013 with proposed effective dates
of June 24, 2013 and October 1, 2013,
respectively. The amendments propose
to provide for supplemental Medicaid
inpatient hospital payments and
disproportionate share hospital (DSH)
payments to private hospitals
participating in public-private
partnerships. These SPAs were
disapproved on May 2, 2014.
The issues to be considered at the
hearing are:
• Whether the state established that
Louisiana SPAs 13–23, 13–25 and 13–28
comply with section 1903(w) of the
Social Security Act (the Act) which
generally provides that state
expenditures are not allowable to the
extent that the state receives certain
provider-related donations and taxes As
set forth in implementing regulations at
42 Code of the Federal Register (CFR)
433.54, expenditures are not allowable,
and federal financial participation (FFP)
is not available, to the extent that the
state receives provider-related donations
and there is a ‘‘hold harmless
arrangement’’ under which providers (or
the provider class) could be effectively
repaid for a provider-related tax or
donation through any direct or indirect
payment, offset, or waiver.
Æ Specifically, at issue is whether (1)
the state established that certain
payments from providers to the state
(characterized by the state as advance
lease payments) were not provider
donations, when the state did not
document such payments to be
consistent with ordinary market
business practices for leasing property;
SUMMARY:
E:\FR\FM\29JYN1.SGM
29JYN1
]]>Agencies
[Federal Register Volume 79, Number 145 (Tuesday, July 29, 2014)]
[Notices]
[Page 44036]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17736]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Candidates To Serve on the Advisory
Committee to the Director, Centers for Disease Control and Prevention
The Centers for Disease Control and Prevention (CDC) is soliciting
nominations for possible membership on the Advisory Committee to the
Director, Centers for Disease Control and Prevention (ACD, CDC). This
committee consists of 15 experts in fields related to health policy,
public health, global health, preparedness, preventive medicine, the
faith-based and community-based sector, and allied fields who are
selected by the Secretary of the U.S. Department of Health and Human
Services (HHS). The committee advises the HHS Secretary and the CDC
Director concerning policy and broad strategies that will enable CDC to
fulfill its mission of protecting health through health promotion,
prevention, and preparedness. The committee recommends ways to
prioritize CDC's activities, improve results, and address health
disparities. It also provides guidance to help CDC work more
effectively with its various private and public sector constituents to
make health protection a practical reality.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishment of the
committee's mission. Nominees will be selected by the HHS Secretary or
designee from authorities knowledgeable in the fields of public health
as well as from the general public. Members may be invited to serve for
terms of up to four years.
The U.S. Department of Health and Human Services policy stipulates
that committee membership shall be balanced in terms of professional
training and background, points of view represented, and the
committee's function. In addition to a broad range of expertise,
consideration is given to a broad representation of geographic areas
within the U.S., with diverse representation of both genders, ethnic
and racial minorities, lesbian, gay, bisexual, and transgender and
persons with disabilities. Nominees must be U.S. citizens, and cannot
be full-time employees of the U.S. Government.
Candidates should submit the following items:
Current curriculum vitae, including complete contact
information (name, affiliation, mailing address, telephone number,
email address);
A letter of recommendation stating the qualifications of
the candidate.
Nomination materials must be postmarked by August 31, 2014, and
sent to: Gayle Hickman, Office of the Chief of Staff, Centers for
Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop D14,
Atlanta, Georgia 30333, telephone (404) 639-7158.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention, and the Agency for
Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-17736 Filed 7-28-14; 8:45 am]
BILLING CODE 4163-18-P
